XPAR
AI
Market cap121bUSD
Jun 18, Last price
167.12EUR
1D
0.13%
1Q
-0.07%
Jan 2017
73.99%
Name
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in Paris, France, in 1902, L'Air Liquide S.A. is a prominent global supplier of industrial and medical gases, cutting-edge technologies, and specialized services. Its extensive operations cover Europe, the Americas, Asia Pacific, the Middle East, and Africa, catering to both industrial and healthcare sectors. The Gas & Services division provides a wide array of fundamental industrial gases, including oxygen, nitrogen, argon, and hydrogen, to key industries such as metallurgy, chemicals, refining, and energy. It also serves manufacturing, automotive, food and pharmaceuticals, technology and research, and retail with gases, associated equipment, and support services. For the healthcare sector, this segment delivers medical gases, hygiene solutions, equipment, and services to hospitals and patients receiving in-home care. Furthermore, it manufactures specialty ingredients for the cosmetics, pharmaceutical, and vaccine industries, and supplies crucial gases and materials for producing semiconductors, flat screens, and photovoltaic panels. The Engineering & Construction segment focuses on designing, developing, and constructing industrial gas production facilities for third parties, in addition to engineering and building plants for conventional, renewable, and alternative energy applications. Lastly, the Global Markets & Technologies segment drives innovation in the energy transition by offering technological solutions, encompassing molecules, equipment, and services. These initiatives support sustainable transport, energy generation, and waste valorization, alongside advancing deep technology in fields such as space exploration, aerospace, and major scientific projects. This segment actively invests in biomethane production, develops infrastructure for natural bio-gas and hydrogen distribution to promote clean mobility, manages biomethane production units for the maritime sector, and supplies gases to offshore oil and gas platforms, wind turbines, and for cryogenic transportation by sea.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||